Alembic Pharma News

11 Sept 20264:33 pm

Business11 Sept 2026 · 4:33 pm4:33 pm

Alembic Pharma's Vadodara Bioequivalence Facility Clears USFDA Inspection with Nil Observations

Alembic Pharmaceuticals announced that its Vadodara facility successfully cleared a USFDA inspection with zero observations, indicating the facility's commitmen

28 Jul 202611:30 pm

pharmaceuticals28 Jul 2026 · 11:30 pm11:30 pm

Create visual

Alembic Pharma Receives USFDA Approval for Generic Chronic Constipation Treatment

Alembic Pharmaceuticals has received final USFDA approval for its generic prucalopride tablets, indicated for chronic idiopathic constipation, which are therape

28 Jul 202611:20 pm

Health28 Jul 2026 · 11:20 pm11:20 pm

Create visual

Alembic Pharma Receives U.S. FDA Approval for Generic Chronic Constipation Drug

Alembic Pharma has received approval from the U.S. FDA for its generic drug used to treat chronic constipation.

19 Jul 20265:19 pm

Business19 Jul 2026 · 5:19 pm5:19 pm

Create visual

Alembic Pharma and NATCO Receive Tentative USFDA Approval for Generic Olaparib Tablets

Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for generic Olaparib tablets, a cancer drug with an estimated US market size of

Alembic Pharma News

#Alembic Pharma

Alembic Pharma's Vadodara Bioequivalence Facility Clears USFDA Inspection with Nil Observations

Alembic Pharma Receives USFDA Approval for Generic Chronic Constipation Treatment

Alembic Pharma Receives U.S. FDA Approval for Generic Chronic Constipation Drug

Alembic Pharma and NATCO Receive Tentative USFDA Approval for Generic Olaparib Tablets

Discover Faster

Stay Organized

Create Effortlessly

Newsroom FAQs

Drive Greater Impact